FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 277

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
KPTI Nasdaq Karyopharm Therapeutics Inc. 2830
KURA Nasdaq Kura Oncology, Inc. 2830
KYTX Nasdaq Kyverna Therapeutics, Inc. 2830
LBRX Nasdaq LB Pharmaceuticals Inc 2830
LENZ Nasdaq LENZ Therapeutics, Inc. 2830
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LONA Nasdaq LeonaBio, Inc. 2830
LYRA Nasdaq Lyra Therapeutics, Inc. 2830
MDGL Nasdaq Madrigal Pharmaceuticals, Inc. 2830
MDWD Nasdaq MediWound Ltd. 2830
MENS Nasdaq Jyong Biotech Ltd. 2830
MESO Nasdaq Mesoblast Limited 2830
MGTX Nasdaq MeiraGTx Holdings plc 2830
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2830
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MNKD Nasdaq MannKind Corporation 2830
MOLN Nasdaq Molecular Partners AG 2830
MREO Nasdaq Mereo BioPharma Group plc 2830
MRK New York Merck & Co., Inc. 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NBY NYSE American NovaBay Pharmaceuticals, Inc. 2830
NCEL Nasdaq NewcelX Ltd. 2830
NCNA Nasdaq NuCana plc 2830
NERV Nasdaq Minerva Neurosciences, Inc. 2830
NGEN Nasdaq NervGen Pharma Corp. 2830
NGNE Nasdaq Neurogene Inc. 2830
NKTR Nasdaq Nektar Therapeutics 2830
NTRB Nasdaq Nutriband Inc. 2830
NUVL Nasdaq Nuvalent, Inc. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
NVS New York Novartis AG 2830
NXTC Nasdaq NextCure, Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
OGEN NYSE American Oragenics, Inc. 2830
OGI Nasdaq Organigram Global Inc. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2830
ONCY Nasdaq Oncolytics Biotech Inc. 2830
ORIC Nasdaq ORIC Pharmaceuticals, Inc. 2830
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBM Nasdaq Psyence Biomedical Ltd. 2830
PBYI Nasdaq Puma Biotechnology, Inc. 2830
PCRX Nasdaq Pacira BioSciences, Inc. 2830
PCVX Nasdaq Vaxcyte, Inc. 2830
Results 150 through 200 of 277